Vemurafenlb Improves Overall Survival Compared to Dacarbazlne In Advanced BRAFV600E-mutated Melanoma: Updated Survival Results From a Phase III Randomised, Open-label, Multlcentre Trial
G. McArthur, A. Hauschild, C. Robert, J.B. Haanen, P. Ascierto, R.J. Lee, K. Nolop, B. Nelson, K.T. Flaherty, P.B. ChapmanVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)70127-7
File:
PDF, 48 KB
english, 2011